TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...
TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (€œAvicanna€ or the €œCompany€) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...
$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an increase of 500% from 2022 TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna...
The 10% CBD (THC free) proprietary oral formulation branded as RHO Phyto Micro Drop 100 in Canada RHO Phyto Micro Drop 100 is available exclusively at MyMedi.ca. TORONTO, March 27, 2024 (GLOBE...
Avicanna To Hold Full Year 2023 Earnings Conference Call
Avicanna Hosts Symposium on Cannabinoid-based Medicine
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (Avicanna or the Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and...
TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (œAvicanna or the œCompany) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and...
Exclusive supply agreement for two of Avicanna™s proprietary topical products in the European region Right of first refusal agreement for the Avicanna™s SEDDs capsules in the European region ...
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (œAvicanna or the œCompany) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and...